Search - tctmd.com

Displaying 61 - 80 of 653

Sort: Relevancy | Date

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Conference News ESOC 2023

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

Todd Neale

June 02, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Conference News AHA 2022

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

Yael L. Maxwell

November 11, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

Presentation TCT 2022

TCT 12: Early Predictors of Left Main and Three-Vessel Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome and Implications for Upstream P2Y12 Inhibitor Administration

Presenter: Rayan Jo Rachwan

September 18, 2022

Presentation TCT 2022

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Presenter: Davide Capodanno

September 18, 2022

Advertisement

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

AHA Scientific Statement Addresses Health Disparities in PAD

Ticagrelor May Be an Option for Averting Brain Lesions During Carotid Stenting

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

TCTMD’s Top 10 Most Popular Stories for February 2023

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

December 2022 News Roundup

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

New Biomarker-Based Risk Score Performs Well in ACS

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

TCT 12: Early Predictors of Left Main and Three-Vessel Coronary Artery Disease in Patients with Non-ST Elevation Acute Coronary Syndrome and Implications for Upstream P2Y12 Inhibitor Administration

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content